|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Newdevelopments of laser processing aluminium alloys via additivemanufacturing technique 显示文摘 | Bartkowiak Konrad Ullrich Sven Frick Thomas | 2011 | Physics Procedia2011，12，： | 1 |
| 2 | Chiral separation of the β--sympathomi- metic fenoterol by HPLC and capillary zone electrophore- sis for pharmacokinetic studies 显示文摘 | THOMAS ULLRICH DIRK WESENBERG CORINNA BLEUEL | 2010 | Biomedical Chroma- tography2010，24，10： | 1 |
| 3 | 无接触测量技术显示文摘在许多生产过程中,温度是一个很重要的测量指标。非接触式红外热辐射高温检测系统是一种性能强大的观察、评定和控制生产过程温度的有效方法,它可以提高生产线加工的质量。 | THOMAS ULLRICH | 2005 | 现代制造2005，，8： | 1 |
| 4 | Materialographic characterization of modern multilayer coating systems used for hot-gas components in large gas turbines for stationary power generation 显示文摘 | Andreas Neidel Susanne Riesenbeck Thomas Ullrich | 2004 | Structure2004，，2： | 1 |
| 5 | Gaussian decomposition and calibration of a novel small-footprint full-waveform digitising airborne laser scanner显示文摘 | Wolfgang Wagner Andreas Ullrich Vesna Ducic Thomas Melzer Nick Studnicka | 2005 | ISPRS Journal of Photogrammetry and Remote Sensing2005，，2： | 1 |
| 6 | Genes associated with Parkinson syndrome显示文摘 | Saskia Biskup Manfred Gerlach Andreas Kupsch Heinz Reichmann Peter Riederer Peter Vieregge Ullrich Wüllner Thomas Gasser | 2008 | Journal of Neurology2008，，： | 1 |
| 7 | Assessing cloud readiness at continental AG显示文摘 | Loebbecke C Thomas B Ullrich T | 2012 | MIS Quarterly Executive2012，11，1： | 1 |
| 8 | Cytohesins Are Cytoplasmic ErbB Receptor Activators显示文摘 | Anke Bill Anton Schmitz Barbara Albertoni Jin-Na Song Lukas C. Heukamp David Walrafen Franziska Thorwirth Peter J. Verveer Sebastian Zimmer Lisa Meffert Arne Schreiber Sampurna Chatterjee Roman K. Thomas Roland T. Ullrich Thorsten Lang Michael Famulok | 2010 | Cell2010，，2： | 1 |
| 9 | No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors显示文摘Background:IgG-class autoantibodies to N-Methyl-D-Aspartate(NMDA)-type glutamate receptors define a novel entity of autoimmune encephalitis.Studies examining the prevalence of NMDA IgA/IgM antibodies in patients with Parkinson disease with/without dementia produced conflicting results.We measured NMDA antibodies in a large,well phenotyped sample of Parkinson patients without and with cognitive impairment(n=296)and controls(n=295)free of neuropsychiatric disease.Detailed phenotyping and large numbers allowed statistically meaningful correlation of antibody status with diagnostic subgroups as well as quantitative indicators of disease severity and cognitive impairment.Methods:NMDA antibodies were analysed in the serum of patients and controls using well established validated assays.We used anti-NMDA antibody positivity as the main independent variable and correlated it with disease status and phenotypic characteristics.Results:The frequency of NMDA IgA/IgM antibodies was lower in Parkinson patients(13%)than in controls(22%)and higher than in previous studies in both groups.NMDA IgA/IgM antibodies were neither significantly associated with diagnostic subclasses of Parkinson disease according to cognitive impairment,nor with quantitative indicators of disease severity and cognitive impairment.A positive NMDA antibody status was positively correlated with age in controls but not in Parkinson patients.Conclusion:It is unlikely albeit not impossible that NMDA antibodies play a significant role in the pathogenesis or progression of Parkinson disease e.g.to Parkinson disease with dementia,while NMDA IgG antibodies define a separate disease of its own. | Franziska Hopfner Stefanie HMüller Dagmar Steppat Joanna Miller Nele Schmidt Klaus-Peter Wandinger Frank Leypoldt Daniela Berg Andre Franke Wolfgang Lieb Lukas Tittmann Monika Balzer-Geldsetzer Simon Baudrexel Richard Dodel Ruediger Hilker-Roggendorf Elke Kalbe Jan Kassubek Thomas Klockgether Inga Liepelt-Scarfone Brit Mollenhauer Petra Neuser Kathrin Reetz Oliver Riedel Claudia Schulte Jörg BSchulz Annika Spottke Alexander Storch Claudia Trenkwalder Hans-Ulrich Wittchen Karsten Witt Ullrich Wüllner Günther Deuschl Gregor Kuhlenbäumer | 2019 | Translational Neurodegeneration2019，8，1： | 0 |
| 10 | 挑战者向领导者的进化论显示文摘近日,波士顿咨询公司发布"2014年全球挑战者报告",年收入至少达到10亿美元并且海外收入占比达到10%或5亿美元是入选全球挑战者百强名单的基本条件。全球挑战者为我们了解新兴市场如何在全球经济中寻找定位开辟了独特的视角。每年的全球挑战者榜单都比前一年更加多样化。随着菲律宾的最新加盟,2014年BCG全球挑战者分别来自18个国家,与2006年首份榜单上的10个国家相比更是增加了近一倍。与同类企业相比,全球挑战者的增长速度更为迅速。 | Marcos Aguiar Thomas Bradtke Erica Carlisle Dinesh Khanna 利嘉伟 麦维德 耐迪贤 Rahool Pai-Panandiker Peter Ullrich | 2014 | 商学院2014，0，11： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员